IOVA

IOVA R&D to Revenue

113.95%Fiscal year

Period ending:

IOVA FY R&D/Revenue%
IOVA FY R&D/Revenue32410.95%-3472.60%
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

IOVA r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Iovance Biotherapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
113.9536%
172.0826%
28,938.3516%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All IOVA financial metrics · IOVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.